Figure 3.
A conceivable therapeutic strategy for patients suspected of having optic neuritis. AQP4-IgG, anti-aquaporin-4 autoantibodies; CRAO, central retinal artery occlusion; CRVO, central retinal vein occlusion; DDx, differential diagnosis; HIV, human immunodeficiency virus; IVMP, intravenous methylprednisolone; MS, multiple sclerosis; MOG-IgG, anti-myelin oligodendrocyte glycoprotein antibody; ON, optic neuritis; STIR, short T1 inversion recovery; T1WI, T1-weighted imaging.